Select Medical Holdings Corporation
NYSE:SEMMedical - Care Facilities
+$0.02 today
- Market cap
- $2.05B
- Beta
- 0.79
- P/E (TTM)
- 15.3
- EPS (TTM)
- $1.08
- Dividend yield
- 1.51%
Volume 14.27M
Average 1.75M
SEM Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Select Medical Holdings CorporationNYSE: SEM
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows, but more slowly than its trailing trend
Q1 FY2026 revenue of $1.42B rose 5.0% year over year, behind the +29.2% change in trailing-twelve-month revenue. Sequentially, it rose 1.8% from the prior quarter. Over 3 fiscal years it compounded at -4.9% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 4 analysts of $5.7B (+4.4%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.42B+1.8% QoQ
- Last fiscal yearDec 2025
- $5.45B+5.1% YoY
- LTMMar 2026
- $5.52B+29.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.0% | +4.3% | -0.7 pp |
| 1 year | +5.1% | +4.4% | -0.7 pp |
| 3-year CAGR | -4.9% | +4.8% | +9.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 5.45B USD
- Year-over-year change
- +5.1%
- 4-year CAGR
- -3.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.45B | +5.1% |
| FY2024 | 2024-12-31 | 5.19B | -22.2% |
| FY2023 | 2023-12-31 | 6.66B | +5.2% |
| FY2022 | 2022-12-31 | 6.33B | +2.1% |
| FY2021 | 2021-12-31 | 6.2B | — |
Revenue vs competitors
How SEM compares with its peers on the latest reported figures
- SEM's LTM Mar 2026 revenue of $5.52B is the 2nd highest of the 11 companies compared; the peer median is $1.91B.
- Its year-over-year change of +29.2% is the 2nd highest of 11, against a peer median of +7.9%.
- Over three fiscal years its annual growth of -4.9% compares with a peer median of +11.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $6.43B | +6.7% | +7.2% |
| LTM Mar 2026 | $5.52B | +29.2% | -4.9% | |
| LTM Mar 2026 | $3.53B | +56.7% | +40.6% | |
| LTM Sep 2026 | $3.41B | +4.5% | +8.3% | |
| LTM Oct 2026 | $2.68B | +16.8% | +10.8% | |
| LTM Sep 2026 | $1.96B | +1.9% | -1.0% | |
| LTM Mar 2026 | $1.85B | +6.5% | +2.8% | |
| LTM Jun 2026 | $1.58B | +20.4% | +18.3% | |
| LTM Sep 2026 | $1.58B | +5.6% | +12.2% | |
| LTM Jun 2026 | $959.9M | +24.3% | +25.6% | |
| LTM Mar 2026 | $729.22M | +9.1% | +12.2% | |
| Peer median (excluding SEM) | $1.91B | +7.9% | +11.5% | |
Competitors are the stored peer set for SEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.2B | 6.33B | 6.66B | 5.19B | 5.45B |
| Cost of Revenue | 5.29B | 5.6B | 5.73B | 4.55B | 4.82B |
| Gross Profit | 919.37M | 733.38M | 932.04M | 633.64M | 629.3M |
| Gross Margin | 14.8% | 11.6% | 14.0% | 12.2% | 11.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 146.98M | 153.04M | 170.19M | 225.87M | 154.41M |
| Operating Expenses | 205.59M | 330.09M | 377.17M | 365.33M | 294.72M |
| Depreciation & Amortization | 202.65M | 205.83M | 208.74M | 203.89M | 140.3M |
| EBITDA | 968.35M | 635.52M | 789.74M | 507.27M | 530.64M |
| EBITDA Margin | 15.6% | 10.0% | 11.9% | 9.8% | 9.7% |
| Operating Income | 713.77M | 403.28M | 554.87M | 268.32M | 334.58M |
| Operating Margin | 11.5% | 6.4% | 8.3% | 5.2% | 6.1% |
| Interest Income | 5.35M | 0 | 0 | 0 | 0 |
| Interest Expense | 135.99M | 169.11M | 198.64M | 128.61M | 117.58M |
| Other Income / Expenses | (84.05M) | (142.7M) | (172.52M) | (93.55M) | (61.83M) |
| Income Before Tax | 629.72M | 260.58M | 382.36M | 174.77M | 272.75M |
| Pre-Tax Margin | 10.1% | 4.1% | 5.7% | 3.4% | 5.0% |
| Income Tax Expense | 129.77M | 62.55M | 82.63M | 44.78M | 58.22M |
| Net Income | 402.23M | 158.99M | 243.49M | 214.04M | 146.22M |
| Net Margin | 6.5% | 2.5% | 3.7% | 4.1% | 2.7% |
| EPS (Basic) | 2.99 | 1.23 | 1.91 | 1.66 | 1.18 |
| EPS (Diluted) | 2.99 | 1.23 | 1.91 | 1.66 | 1.18 |
| Weighted Avg Shares | 130.25M | 124.63M | 123.11M | 129.19M | 123.51M |
| Weighted Avg Shares (Diluted) | 130.25M | 124.63M | 123.11M | 124.61M | 123.51M |
Select Medical Holdings Corporation
NYSE:SEM
Intrinsic Alpha fair value
Locked
Current Price
$16.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.